HARTE HANKS INC (HHS) — Institutional Holders, Q2 2026
22 institutional investment managers reported a HHS position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $4.5M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
HHS in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Krilogy FinancialAdded · +34,204 sh+$73.9K
- WESTERLY CAPITAL MANAGEMENTAdded · +8,000 sh+$17.3K
- MORGAN STANLEYAdded · +5 sh+$11.00
- BARCLAYS PLCNew · +2 sh+$4.00
Biggest sellers
- SUSQUEHANNA INTERNATIONAL GROUP, LLPSold out · -17,623 sh-$38.1K
- BlackRockTrimmed · -9,833 sh-$21.2K
- BRIDGEWAY CAPITAL MANAGEMENTTrimmed · -6,500 sh-$14.0K
- GEODE CAPITAL MANAGEMENTTrimmed · -2,889 sh-$6.2K
- RENAISSANCE TECHNOLOGIESTrimmed · -800 sh-$1.7K
HHS 13F holders ranked 1–22 of 22
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | BLAIR WILLIAM#1 · 660,845 sh | 660,845 | $1.4M | <0.01% | 0.0% |
| 2 | WESTERLY CAPITAL MANAGEMENT#2 · 635,000 sh | 635,000 | $1.4M | 0.25% | +1.3% |
| 3 | VANGUARD CAPITAL MANAGEMENT#3 · 259,036 sh | 259,036 | $559.5K | 0.00% | 0.0% |
| 4 | Krilogy Financial#4 · 152,379 sh | 152,379 | $329.1K | — | +28.9% |
| 5 | RAFFLES ASSOCIATES#5 · 87,757 sh | 87,757 | $189.6K | 0.17% | 0.0% |
| 6 | GEODE CAPITAL MANAGEMENT#6 · 54,988 sh | 54,988 | $118.8K | 0.00% | -5.0% |
| 7 | DIMENSIONAL FUND ADVISORS#7 · 42,621 sh | 42,621 | $92.1K | 0.00% | 0.0% |
| 8 | ACADIAN ASSET MANAGEMENT#8 · 32,478 sh | 32,478 | $70.0K | <0.01% | -0.2% |
| 9 | VANGUARD FIDUCIARY#9 · 30,619 sh | 30,619 | $66.1K | 0.00% | 0.0% |
| 10 | STATE STREET#10 · 26,497 sh | 26,497 | $57.2K | 0.00% | 0.0% |
| 11 | BRIDGEWAY CAPITAL MANAGEMENT#11 · 26,100 sh | 26,100 | $56.4K | <0.01% | -19.9% |
| 12 | RENAISSANCE TECHNOLOGIES#12 · 21,400 sh | 21,400 | $46.2K | <0.01% | -3.6% |
| 13 | BlackRock#13 · 19,028 sh | 19,028 | $41.1K | 0.00% | -34.1% |
| 14 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP#14 · 17,204 sh | 17,204 | $37.2K | 0.00% | 0.0% |
| 15 | LSV ASSET MANAGEMENT#15 · 12,700 sh | 12,700 | $27.0K | 0.00% | 0.0% |
| 16 | Vanguard Global Advisers#16 · 1,918 sh | 1,918 | $4.1K | 0.00% | 0.0% |
| 17 | Tower Research Capital (TRC)#17 · 1,725 sh | 1,725 | $3.7K | <0.01% | -13.5% |
| 18 | UBS Group AG#18 · 152 sh | 152 | $328.00 | 0.00% | -26.6% |
| 19 | Triumph Capital Management#19 · 86 sh | 86 | $186.00 | — | 0.0% |
| 20 | MORGAN STANLEY#20 · 12 sh | 12 | $26.00 | 0.00% | +71.4% |
| 21 | BARCLAYS PLC#21 · 2 sh | 2 | $4.00 | 0.00% | New |
| 22 | WELLS FARGO & COMPANY#22 · 1 sh | 1 | $2.00 | 0.00% | 0.0% |
Funds that sold out of HHS in Q2 2026 (1)
Held HHS at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP17,623 sh | 17,623 | $40.0K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.